148 related articles for article (PubMed ID: 26971271)
1. Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.
Gramer I; Kessler M; Geyer J
Vet Res Commun; 2016 Jun; 40(2):89-95. PubMed ID: 26971271
[TBL] [Abstract][Full Text] [Related]
2. A multicancer-like syndrome in a dog characterized by p53 and cell cycle-checkpoint kinase 2 (CHK2) mutations and sirtuin gene (SIRT1) down-regulation.
Marfe G; De Martino L; Tafani M; Irno-Consalvo M; Pasolini MP; Navas L; Papparella S; Gambacurta A; Paciello O
Res Vet Sci; 2012 Aug; 93(1):240-5. PubMed ID: 21890154
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.
Heishima K; Ichikawa Y; Yoshida K; Iwasaki R; Sakai H; Nakagawa T; Tanaka Y; Hoshino Y; Okamura Y; Murakami M; Maruo K; Akao Y; Mori T
Sci Rep; 2017 May; 7(1):2301. PubMed ID: 28536479
[TBL] [Abstract][Full Text] [Related]
4. Identification of the two KIT isoforms and their expression status in canine hemangiosarcomas.
Chen YC; Liao JW; Hsu WL; Chang SC
BMC Vet Res; 2016 Jul; 12(1):142. PubMed ID: 27422008
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species.
Tawa GJ; Braisted J; Gerhold D; Grewal G; Mazcko C; Breen M; Sittampalam G; LeBlanc AK
PLoS Comput Biol; 2021 Sep; 17(9):e1009450. PubMed ID: 34570764
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of tyrosine kinases and use of imatinib in small animal practice.
Bonkobara M
Vet J; 2015 Aug; 205(2):180-8. PubMed ID: 25592261
[TBL] [Abstract][Full Text] [Related]
7. Swiss Canine Cancer Registry 1955-2008: Occurrence of the Most Common Tumour Diagnoses and Influence of Age, Breed, Body Size, Sex and Neutering Status on Tumour Development.
Grüntzig K; Graf R; Boo G; Guscetti F; Hässig M; Axhausen KW; Fabrikant S; Welle M; Meier D; Folkers G; Pospischil A
J Comp Pathol; 2016; 155(2-3):156-170. PubMed ID: 27406312
[TBL] [Abstract][Full Text] [Related]
8. Disease distribution in canine patients with acanthocytosis: 123 cases.
Warry E; Bohn A; Emanuelli M; Thamm D; Lana S
Vet Clin Pathol; 2013 Dec; 42(4):465-70. PubMed ID: 24320780
[TBL] [Abstract][Full Text] [Related]
9. Relevance of Molecular Changes in the ND4 Gene in German Shepherd Dog Tumours.
Ślaska B; Grzybowska-Szatkowska L; Bugno-Poniewierska M; Gurgul A; Śmiech A; Różańska D; Dudka J
Pol J Vet Sci; 2016 Sep; 19(3):461-469. PubMed ID: 27760018
[TBL] [Abstract][Full Text] [Related]
10. Heteroplasmic Mutations and Polymorphisms in the
Śmiech A; Ślaska B; Bownik A; Grzybowska-Szatkowska L; Dudka J; Łopuszyński W
In Vivo; 2019; 33(1):57-63. PubMed ID: 30587603
[TBL] [Abstract][Full Text] [Related]
11. Identification of additional mitochondrial DNA mutations in canine mast cell tumours.
Śmiech A; Ślaska B; Surdyka M; Grzybowska-Szatkowska L; Łopuszyński W; Różańska D
Acta Vet Scand; 2016 May; 58(1):28. PubMed ID: 27146669
[TBL] [Abstract][Full Text] [Related]
12. RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target.
Thamm DH; Huelsmeyer MK; Mitzey AM; Qurollo B; Rose BJ; Kurzman ID
Melanoma Res; 2010 Feb; 20(1):35-42. PubMed ID: 19949352
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?
Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Martini V; Comazzi S; Dacasto M
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):325-32. PubMed ID: 23375718
[TBL] [Abstract][Full Text] [Related]
14. Positive association between a glutathione-S-transferase polymorphism and lymphoma in dogs.
Ginn J; Sacco J; Wong YY; Motsinger-Reif A; Chun R; Trepanier LA
Vet Comp Oncol; 2014 Sep; 12(3):227-36. PubMed ID: 23020265
[TBL] [Abstract][Full Text] [Related]
15. Results of radiation treatment of naturally occurring animal tumors.
Banks WC; Morris E
J Am Vet Med Assoc; 1975 Jun; 166(11):1063-4. PubMed ID: 166056
[No Abstract] [Full Text] [Related]
16. p53 expression in canine lymphoma.
Sokołowska J; Cywińska A; Malicka E
J Vet Med A Physiol Pathol Clin Med; 2005 May; 52(4):172-5. PubMed ID: 15882401
[TBL] [Abstract][Full Text] [Related]
17. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis identified up-regulation of a solute carrier transporter and UDP glucuronosyltransferases in dogs with aggressive cutaneous mast cell tumours.
Giantin M; Baratto C; Marconato L; Vascellari M; Mutinelli F; Dacasto M; Granato A
Vet J; 2016 Jun; 212():36-43. PubMed ID: 27256023
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of cyclooxygenase-2 related multi-drug resistance gene in melanoma and osteosarcoma cell lines by TSG-6 secreted from canine adipose-derived mesenchymal stem/stromal cells.
Yang SJ; An JH; Park SM; Lee JH; Chae HK; Lee KM; Song WJ; Youn HY
Vet Med Sci; 2021 May; 7(3):968-978. PubMed ID: 33570264
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumours.
Rezaie A; Tabandeh MR; Noori SM
Vet Comp Oncol; 2016 Jun; 14(2):137-46. PubMed ID: 24447820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
